Related Experiment Videos
Increased CSF IgM in multiple sclerosis
Neurology
|October 1, 1978
Summary
Elevated cerebrospinal fluid immunoglobulin M (IgM) is common in multiple sclerosis (MS) patients, occurring independently of immunoglobulin G (IgG) levels. This finding may offer new insights into MS pathogenesis.
Area of Science:
- Neurology
- Immunology
- Biochemistry
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- Immunoglobulin G (IgG) abnormalities in cerebrospinal fluid (CSF) are well-documented in MS.
- The role of other immunoglobulins, such as immunoglobulin M (IgM), in MS pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the prevalence and characteristics of CSF IgM levels in patients with MS.
- To determine the relationship between CSF IgM and CSF IgG levels in MS.
- To explore potential correlations between CSF IgM levels and clinical parameters of MS.
Main Methods:
- Radioimmunoassay was utilized to measure CSF IgM levels.
- Patient cohorts included 56 individuals with MS, 62 with other neurologic diseases, and 31 healthy controls.
- Statistical analysis was performed to compare IgM levels across groups and assess correlations.
Main Results:
- A significantly higher proportion of MS patients (48%) exhibited elevated CSF IgM compared to patients with other neurologic diseases (5%).
- CSF IgM levels did not correlate with CSF IgG levels in MS patients.
- Approximately 40% of MS patients with normal IgG levels still presented with high IgM levels.
- No significant association was found between CSF IgM levels and MS disease duration, severity, relapses, or steroid treatment.
Conclusions:
- Elevated CSF IgM is a frequent finding in multiple sclerosis, distinct from IgG abnormalities.
- CSF IgM may represent a potential biomarker or contribute to MS pathophysiology, independent of IgG.
- Further research is warranted to elucidate the specific role and origin of IgM in MS.